Truqap combination showed a statistically and clinically meaningful improvement in radiographic progression-free survival for ...

By law, smokers with severe tobacco dependence are entitled to receive one-off drug therapy for smoking cessation as part of ...

US-based immuno-oncology company Aulos Bioscience has announced the first patients have been dosed as part of a trial ...

Verastem's promising progress in RAS-driven cancers, potential FDA approval, and growth opportunities present a bullish ...

LBS-007, a novel targeted therapy, has received FDA fast track designation for the treatment of acute myeloid leukemia.

Verona's approval of ensifentrine in COPD offers promising potential with its MoA and safety profile in a competitive market.

Long-awaited joint UK guidelines for asthma have today been finalised, overhauling recommendations to GPs for diagnostics and ...

DTG/FTC was effective for long-term HIV management with a good safety profile, suggesting it may be a viable alternative option to 3-drug ART regimens.

The FDA has received a biologics license application submission for RP1 plus nivolumab in patients with PD-1 ...

Medicenna Presents Preclinical Data on MDNA11 and Bizaxofusp at the 2024 Annual Meeting of the Society for Neuro-Oncology (SNO) ...

The US Food and Drug Administration (FDA) is expected to make a Prescription Drug User Fee Act (PDUFA) decision by mid-2025.